Atlas Trials

A Phase 1b Study to Evaluate the Safety of XEN-101

Clinical trial NCT06417697 · TERMINATED

Trial details

NCT number
NCT06417697
Sponsor
Xeno Biosciences
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Obesity
Start date
2024-05-24
Primary completion
2024-09-09
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.